(Q36689038)

15 August 2017

1 reference

title

Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials (English)

1 reference

15 August 2017

1 reference

1 reference

Miriam E Mossoba

1

1 reference

PubMed ID

17181444

15 August 2017

Jeffrey A Medin

series ordinal

2

1 reference

15 August 2017

1 October 2006

1 reference

Expert Review of Vaccines

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

5

1 reference

15 August 2017

717-732

1 reference

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Some interfaces of dendritic cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Dendritic cells as vectors for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Cancer immunotherapy with mRNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Gene therapy clinical trials worldwide 1989-2004-an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Dependence of adenovirus infectivity on length of the fiber shaft domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Poxviruses as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Poxvirus vaccines for cancer and HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Retroviral vectors: new applications for an old tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Progress and problems with the use of viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Latest development in viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Lentiviral vector-transduced dendritic cells induce specific T cell response in a nonhuman primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Current issues in delivering DCs for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Immune regulation in tumor-bearing hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.717

21 January 2018

Identifiers

DOI

10.1586/14760584.5.5.717

1 reference

15 August 2017

1 reference

PubMed ID

17181444